Speaking with MedImmune’s President, Peter Greenleaf, pharmaphorum finds that the challenges and opportunities faced by MedImmune in developing commercially successful biological therapies in ...
GlobalData on MSN3mon
Aurinia slashes workforce by 45% to focus on lupus and autoimmune assetsIn the statement accompanying the Q3 results, CEO Peter Greenleaf said the workforce reduction would “strengthen Aurinia’s ...
It was shortly before 4 a.m. when Greenleaf woke up and started moving about the rectory, which is attached to the Basilica of Saints Peter and Paul on Ash Street in Lewiston. He was meeting with ...
Hosted on MSN1mon
Aurinia Pharma Surges Pre-Market After Director Kevin Tang Discloses $10M Stock Buy: Retail Confidence SpikesThis came alongside changes to its board of directors, including Tang’s appointment, following CEO Peter Greenleaf’s conditional resignation as director. In its third-quarter (Q3) earnings ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback